Health & Biotech

Clinical decision support (CDS)

Also known as: CDS, clinical decision support system, CDSS

Clinical decision support (CDS) is technology that gives clinicians relevant information or recommendations at the moment they make decisions: a warning about a dangerous drug interaction, a reminder that a patient is due for screening, or an AI alert predicting sepsis.

Good CDS prevents errors and improves care. While its potential is huge, poorly designed CDS creates 'alert fatigue,' where clinicians ignore so many warnings that the important ones get lost.

Clinical decision support (CDS), explained at three levels

At home

Think of a car's lane-departure warning. It does not drive for you, but it beeps when you drift. Clinical decision support does that for clinicians. Software in the health record checks what is being ordered or recorded against rules and data, and warns about a dangerous drug combination, reminds about an overdue screening, or flags a patient who may be getting sicker.

At work

Clinical decision support is technology that gives clinicians patient-specific information or recommendations within their workflow, such as drug interaction checks, order sets, reminders, and risk predictions. For health organizations, it is a main tool for standardizing care, preventing errors, and meeting quality targets, but badly tuned CDS wastes clinician time and teaches people to ignore warnings.

Real-world examples

At home

Aisha's doctor tried to prescribe an antibiotic, and the system warned it could interact with Aisha's blood thinner. The doctor chose a different antibiotic, avoiding a risky bleeding complication.

At work

Fatima is a chief medical information officer at an Ontario hospital. Her team reviewed drug alerts and found that 95% were overridden. They turned off the lowest-value alerts, and override rates on the remaining critical warnings dropped noticeably.

How it compares

featureRule-based CDSAI-based CDS
LogicIf-then rules written by expertsPredictions learned from data
TransparencyEasy to explainOften harder to explain
ExampleDrug allergy warningSepsis or deterioration prediction
Main riskToo many irrelevant alertsPoor accuracy in new settings

Rules are predictable but blunt. AI is adaptive but needs validation.

For analysts

Every new alert costs clinician attention. I'd require each CDS rule or model to have a named owner, a measured benefit, and a review date, and retire the ones that don't earn their interruption.

History & origin

Early computer systems such as MYCIN, developed at Stanford in the 1970s to recommend antibiotics, showed computers could reason about medicine but were never used clinically. The Regenstrief Institute and Intermountain Healthcare built CDS into records systems in the 1970s and 1980s. As electronic health records spread in the 2000s and 2010s, drug-interaction alerts and order sets became standard. Studies found clinicians overrode most alerts, sometimes over 90% of them. In 2021, a JAMA Internal Medicine study of a widely used proprietary sepsis prediction model found it missed about two-thirds of sepsis cases while alerting on many patients who didn't have it. In my view, that study changed the conversation: AI in clinical settings needs independent validation, not vendor assurances.